Companies Dominating the Pharmaceutical Microbiology Landscape
- NEOGEN Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Hardy Diagnostics
- IDEXX
- Charles River Laboratories
- BioMerieux SA
- Merck KGAA
- Rapid Micro Biosystems.
- Abbott Laboratories, Inc
- Bio-Rad Laboratories
- Gen-Probe, Inc
Browse Key Market Insights with Data Illustration:
In the News
- NEOGEN Corporation unveiled Soleris® Next Generation (NG). The novel Soleris® Next Generation (NG) from NEOGEN is capable of quickly identifying a broad range of bacteria that may jeopardize the quality and safety of food and other consumer goods. For instance, whereas traditional methods require three to five days to identify and count yeast and mold in a sample, Solaris NG can do so in just 48 hours. Additionally, it can identify Alicyclobacillus, a bacterium of special concern to the fruit juice industry, in just 48 hours as opposed to five days using other methods.
- Hardyc Diagnostics designed CmpactDry TCR, a ready-to-use dehydrated culture medium plate to identify and count microorganisms. It can yield total aerobic plate counts in as little as 24 hours. Being AOAC PTM (Association of Official Analytical Chemists - Performance Tested Methods) approved, this self-diffusing plate is the simplest to use for plate counts since it doesn't require spreading or stamping. Just take off the lid, pour 1 milliliter of sample onto the middle of the plate, replace the lid, and let it incubate.
